Anixa Biosciences, Inc. ANIX
$2.64
-1.12%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 4 | 4 | 2026-09-30 | View → |
| 4 | 4 | 2026-09-28 | View → |
| 4 | 4 | 2026-09-28 | View → |
| 4 | 4 | 2026-09-25 | View → |
| 4 | 4 | 2026-09-14 | View → |
| 4 | 4 | 2026-09-14 | View → |
| 4 | 4 | 2026-09-11 | View → |
| 10-Q | 10-Q | 2026-09-09 | View → |
| 4 | 4 | 2026-08-03 | View → |
| 4 | 4 | 2026-07-29 | View → |
| 4 | 4 | 2026-07-28 | View → |
| 4 | 4 | 2026-07-27 | View → |
| 4 | 4 | 2026-07-27 | View → |
| 4 | 4 | 2026-07-21 | View → |
| 4 | 4 | 2026-07-20 | View → |
| 4 | 4 | 2026-07-16 | View → |
| 4 | 4 | 2026-07-13 | View → |
| 4 | 4 | 2026-06-17 | View → |
| 4 | 4 | 2026-06-16 | View → |
| 10-Q | 10-Q | 2026-06-10 | View → |
| 8-K | 8-K | 2026-03-11 | View → |
| 10-Q | 10-Q | 2026-03-09 | View → |
| 8-K | 8-K | 2026-02-09 | View → |
| 4 | 4 | 2026-01-29 | View → |
| DEF 14A | DEF 14A | 2026-01-28 | View → |
| 10-K | 10-K | 2026-01-12 | View → |
| 4 | 4 | 2026-01-06 | View → |
| 4 | 4 | 2026-01-06 | View → |
| 4 | 4 | 2026-01-06 | View → |
| 4 | 4 | 2026-01-06 | View → |
| 4 | 4 | 2026-01-06 | View → |
| 4 | 4 | 2025-12-16 | View → |
| 8-K | 8-K | 2025-12-12 | View → |
| 4 | 4 | 2025-10-31 | View → |
| S-3 | S-3 | 2025-09-10 | View → |
| 10-Q | 10-Q | 2025-09-10 | View → |
| 4 | Insider transaction | 2025-08-04 | View → |
| 4 | Insider transaction | 2025-07-31 | View → |
| 4 | Insider transaction | 2025-07-21 | View → |
| 4 | Insider transaction | 2025-07-15 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $2.64
- Market Cap
- $92.82 million
- 52-Week Range
- $2.32 – $5.46
- Average Volume
- 341K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.